| ISIN | LU1159238978 |
|---|---|
| Valor Number | 29067531 |
| Bloomberg Global ID | |
| Fund Name | State Street UK Screened Index Equity Fund I EUR |
| Fund Provider |
State Street Investment Management
Kalanderplatz 5, 8045 Zürich E-Mail: spdrsswitzerland@statestreet.com Web: www.statestreet.com/im spdrsswitzerland@statestreet.com (ETF Business) |
| Fund Provider | State Street Investment Management |
| Representative in Switzerland |
State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 |
| Distributor(s) | State Street Global Advisors |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | The objective of the Fund is to track the performance of the UK equity market. |
| Peculiarities |
| Current Price * | 18.76 EUR | 31.10.2025 |
|---|---|---|
| Previous Price * | 18.84 EUR | 30.10.2025 |
| 52 Week High * | 18.84 EUR | 30.10.2025 |
| 52 Week Low * | 14.83 EUR | 09.04.2025 |
| NAV * | 18.76 EUR | 31.10.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 97,465,949 | |
| Unit/Share Assets *** | 78,475,295 | |
| Trading Information SIX | ||
| YTD Performance | +13.87% |
31.12.2024 - 31.10.2025
31.12.2024 31.10.2025 |
|---|---|---|
| YTD Performance (in CHF) | +13.15% |
31.12.2024 - 31.10.2025
31.12.2024 31.10.2025 |
| 1 month | +4.48% |
30.09.2025 - 31.10.2025
30.09.2025 31.10.2025 |
| 3 months | +6.18% |
31.07.2025 - 31.10.2025
31.07.2025 31.10.2025 |
| 6 months | +11.85% |
30.04.2025 - 31.10.2025
30.04.2025 31.10.2025 |
| 1 year | +17.86% |
31.10.2024 - 31.10.2025
31.10.2024 31.10.2025 |
| 2 years | +38.70% |
31.10.2023 - 31.10.2025
31.10.2023 31.10.2025 |
| 3 years | +45.89% |
31.10.2022 - 31.10.2025
31.10.2022 31.10.2025 |
| 5 years | +112.32% |
02.11.2020 - 31.10.2025
02.11.2020 31.10.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HSBC Holdings PLC | 9.68% | |
|---|---|---|
| AstraZeneca PLC | 9.21% | |
| Shell PLC | 8.28% | |
| Unilever PLC | 5.74% | |
| BP PLC | 3.58% | |
| RELX PLC | 3.46% | |
| GSK PLC | 3.41% | |
| Rio Tinto PLC Ordinary Shares | 2.92% | |
| Barclays PLC | 2.87% | |
| National Grid PLC | 2.77% | |
| Last data update | 30.09.2025 | |
| TER *** | 0.30% |
|---|---|
| TER date *** | 30.06.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.20% |
| Ongoing Charges *** | 0.30% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2025 |